Brain Tumor Treatments: Kentucky

Sponsored By

Please Click On The Above Banner For More Details

[Click HERE to print this page!]

Search Term: Kentucky
Please scroll down to see the matching trials.

  (0.8351) Brain Tumor Treatments: Kentucky
  (0.7742) Untitled Document
  (0.7742) RSR-13
  (0.7742) RSR-13
  (0.7742) RSR-13
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism

Sorry - There were no pages found that contain that search phrase.


	Treatment	Location	Last Updated

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	Louisville, KY USA	05/30/2006

Details	Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics	Louisville, KY USA	05/29/2006

Details	A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion	Louisville, KY USA	05/27/2006

Details	Genetic Epidemiology of Adult-Onset Glioma	Louisville, KY USA	05/27/2006

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Louisville, KY USA	11/27/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Lexington, KY USA	11/27/2005

Details	Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors	Louisville, KY USA	11/26/2005

Details	A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection	Lexington, KY USA	11/13/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Lexington, KY USA	11/06/2005